Lin Nancy W, Liu Cuining, Yang Ivana V, Maier Lisa A, DeMeo Dawn L, Wood Cheyret, Ye Shuyu, Cruse Margaret H, Smith Vong L, Vyhlidal Carrie A, Kechris Katerina, Sharma Sunita
Division of Environmental and Occupational Health, National Jewish Health, Denver, CO, United States.
Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, United States.
Front Genet. 2022 Apr 11;13:762834. doi: 10.3389/fgene.2022.762834. eCollection 2022.
Sex-specific differences in fetal lung maturation have been well described; however, little is known about the sex-specific differences in microRNA (miRNA) expression during human fetal lung development. Interestingly, many adult chronic lung diseases also demonstrate sex-specific differences in prevalence. The developmental origins of health and disease hypothesis suggests that these sex-specific differences in fetal lung development may influence disease susceptibility later in life. In this study, we performed miRNA sequencing on human fetal lung tissue samples to investigate differential expression of miRNAs between males and females in the pseudoglandular stage of lung development. We hypothesized that differences in miRNA expression are present between sexes in early human lung development and may contribute to the sex-specific differences seen in pulmonary diseases later in life. RNA was isolated from human fetal lung tissue samples for miRNA sequencing. The count of each miRNA was modeled by sex using negative binomial regression models in DESeq2, adjusting for post-conception age, age, smoke exposure, batch, and RUV factors. We tested for differential expression of miRNAs by sex, and for the presence of sex-by-age interactions to determine if miRNA expression levels by age were distinct between males and females. miRNA expression profiles were generated on 298 samples (166 males and 132 females). Of the 809 miRNAs expressed in human fetal lung tissue during the pseudoglandular stage of lung development, we identified 93 autosomal miRNAs that were significantly differentially expressed by sex and 129 miRNAs with a sex-specific pattern of miRNA expression across the course of the pseudoglandular period. Our study demonstrates differential expression of numerous autosomal miRNAs between the male and female developing human lung. Additionally, the expression of some miRNAs are modified by age across the pseudoglandular stage in a sex-specific way. Some of these differences in miRNA expression may impact susceptibility to pulmonary disease later in life. Our results suggest that sex-specific miRNA expression during human lung development may be a potential mechanism to explain sex-specific differences in lung development and may impact subsequent disease susceptibility.
胎儿肺成熟过程中的性别差异已得到充分描述;然而,关于人类胎儿肺发育过程中微小RNA(miRNA)表达的性别差异却知之甚少。有趣的是,许多成人慢性肺部疾病在患病率上也表现出性别差异。健康与疾病的发育起源假说表明,胎儿肺发育中的这些性别差异可能会影响生命后期的疾病易感性。在本研究中,我们对人类胎儿肺组织样本进行了miRNA测序,以研究肺发育假腺期男性和女性之间miRNA的差异表达。我们假设在人类肺早期发育过程中,性别之间存在miRNA表达差异,这可能导致生命后期肺部疾病中出现的性别差异。从人类胎儿肺组织样本中分离RNA用于miRNA测序。在DESeq2中使用负二项回归模型按性别对每个miRNA的计数进行建模,并对受孕后年龄、年龄、吸烟暴露、批次和RUV因子进行调整。我们测试了miRNA按性别的差异表达,以及性别与年龄交互作用的存在,以确定男性和女性按年龄的miRNA表达水平是否不同。在298个样本(166名男性和132名女性)上生成了miRNA表达谱。在肺发育假腺期人类胎儿肺组织中表达的809种miRNA中,我们鉴定出93种常染色体miRNA在性别上有显著差异表达,以及129种在整个假腺期具有性别特异性miRNA表达模式的miRNA。我们的研究表明,在发育中的人类肺的男性和女性之间,许多常染色体miRNA存在差异表达。此外,一些miRNA的表达在整个假腺期按性别特异性方式随年龄而改变。这些miRNA表达的一些差异可能会影响生命后期对肺部疾病的易感性。我们的结果表明,人类肺发育过程中性别特异性的miRNA表达可能是解释肺发育中性别差异的潜在机制,并可能影响随后的疾病易感性。